NOTICE: We are experiencing technical issues with Academy members trying to log into the JAND site using Academy member login credentials. We are working to resolve the issue as soon as possible. Alternatively, if you are an Academy member, you can access the JAND site by registering for an Elsevier account and claiming access using the links at the top of the JAND site. Email us at [email protected] for assistance. Thanks for your patience!

The Association Between Computed Tomography–Defined Sarcopenia and Outcomes in Adult Patients Undergoing Radiotherapy of Curative Intent for Head and Neck Cancer: A Systematic Review

      Abstract

      Background

      Computed tomography (CT)-defined sarcopenia is a demonstrated poor prognostic factor in patients with cancer; however, its influence on outcomes for patients with head and neck cancer (HNC) has not been established.

      Objective

      This review synthesizes current knowledge regarding the association between CT-defined sarcopenia and outcomes for adult patients undergoing radiotherapy with or without other treatment modalities of curative intent for HNC.

      Methods

      A systematic review of the literature published between January 2004 and June 2019 was conducted in Medline, Embase, Cumulative Index of Nursing and Allied Health Literature, Allied and Complementary Medicine Database, and PubMed. Empirical studies of CT-defined sarcopenia in adult patients (≥18 years) with HNC who had completed radiotherapy of curative intent with or without other treatment modalities were included. Outcomes reported included survival, prolonged radiotherapy breaks, and chemotherapy toxicity. Study quality was assessed using the American Academy of Nutrition and Dietetics Quality Criteria Checklist. Synthesis of outcomes and clinical relevance was performed using the Grading of Recommendations Assessment, Development, and Evaluation system.

      Results

      Of 11 studies (n = 3,461) identified, 3 were positive and 8 were neutral quality. Studies were heterogeneous in HNC diagnosis, ethnicity, definition of sarcopenia, CT level of evaluation, and skeletal muscle index threshold value. Eight definitions for sarcopenia were identified with pretreatment prevalence of 6.6% to 70.9% and posttreatment prevalence of 12.4% to 65.8%. Pretreatment sarcopenia was independently associated with reduced: overall survival (OS), 3-year OS, disease-free survival, prolonged radiotherapy breaks, and chemotherapy-related toxicities. Posttreatment sarcopenia was independently associated with reduced OS and 5-year OS. The overall certainty of evidence according to Grading of Recommendations Assessment, Development and Evaluation criteria was low for OS; 3-year, 5-year, and 10-year OS; locoregional control; locoregional failure; progression-free survival; metastasis-free survival, disease-specific survival; and disease-free survival and very low for distant metastasis, prolonged radiotherapy breaks, and chemotherapy toxicity-related outcomes.

      Conclusions

      CT-defined sarcopenia is independently associated with reduced OS and treatment completion in patients with HNC and holds a clinically meaningful prognostic value. The certainty of the evidence requires strengthening with further research. Understanding the impact sarcopenia has on outcomes for these patients has implications for informing potential nutrition interventions and facilitating individualized care.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Academy of Nutrition and Dietetics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • World Health Organization
        Locally Advanced Squamous Carcinoma of the Head and Neck.
        World Health Organization, Geneva, Switzerland2014
        • Platek M.E.
        • Popp J.V.
        • Possinger C.S.
        • Denysschen C.A.
        • Horvath P.
        • Brown J.K.
        Comparison of the prevalence of malnutrition diagnosis in head and neck, gastrointestinal, and lung cancer patients by 3 classification methods.
        Cancer Nurs. 2011; 34: 410-416
        • Department of Health and Human Services
        Phase II Malnutrition in Victorian Cancer Services: Summary Report.
        State Government of Victoria, Melbourne, Victoria, Australia2015
        • Alshadwi A.
        • Nadershah M.
        • Carlson E.R.
        • Young L.S.
        • Burke P.A.
        • Daley B.J.
        Nutritional considerations for head and neck cancer patients: A review of the literature.
        J Oral Maxillofac Surg. 2013; 71: 1853-1860
        • Simeoni R.
        • Breitenstein K.
        • Esser D.
        • Guntinas-Lichius O.
        Cardiac comorbidity in head and neck cancer patients and its influence on cancer treatment selection and mortality: A prospective cohort study.
        Eur Arch Otorhinolaryngol. 2016; 273: 2765-2772
        • Moon H.
        • Roh J.L.
        • Lee S.W.
        • et al.
        Prognostic value of nutritional and hematologic markers in head and neck squamous cell carcinoma treated by chemoradiotherapy.
        Radiother Oncol. 2016; 118: 330-334
      1. Findlay M, Bauer J, Brown T, et al. Evidence-based practice guidelines for the nutritional management of adult patients with head and neck cancer. Sydney, Australia: Cancer Council Australia. http://wiki.cancer.org.au/australia/COSA:Head_and_neck_cancer_nutrition_guidelines. Published 2011. Updated June 19, 2016. Accessed June 4, 2019.

        • Thompson K.L.
        • Elliott L.
        • Fuchs-Tarlovsky V.
        • Levin R.M.
        • Voss A.C.
        • Piemonte T.
        Oncology evidence-based nutrition practice guideline for adults.
        J Acad Nutr Diet. 2017; 117: 297-310 e247
        • Charuhas Macris P.
        • Schilling K.
        • Palko R.
        Academy of Nutrition and Dietetics: Revised 2017 standards of practice and standards of professional performance for registered dietitian nutritionists (competent, proficient, and expert) in oncology nutrition.
        J Acad Nutr Diet. 2018; 118: 736-748 e742
        • Arends J.
        • Bachmann P.
        • Baracos V.
        • et al.
        ESPEN guidelines on nutrition in cancer patients.
        Clin Nutr. 2017; 36: 11-48
        • Trujillo E.B.
        • Dixon S.W.
        • Claghorn K.
        • Levin R.M.
        • Mills J.B.
        • Spees C.K.
        Closing the gap in nutrition care at outpatient cancer centers: Ongoing initiatives of the Oncology Nutrition Dietetic Practice Group.
        J Acad Nutr Diet. 2018; 118: 749-760
        • Sheean P.
        • Gonzalez M.C.
        • Prado C.M.
        • McKeever L.
        • Hall A.M.
        • Braunschweig C.A.
        American Society for Parenteral and Enteral Nutrition clinical guidelines: The validity of body composition assessment in clinical populations.
        JPEN J Parenter Enteral Nutr. 2020; 44: 12-43
        • Fearon K.
        • Strasser F.
        • Anker S.D.
        • et al.
        Definition and classification of cancer cachexia: An international consensus.
        Lancet Oncol. 2011; 12: 489-495
        • Fearon K.
        • Arends J.
        • Baracos V.
        Understanding the mechanisms and treatment options in cancer cachexia.
        Nat Rev Clin Oncol. 2013; 10: 90-99
        • Baracos V.E.
        • Martin L.
        • Korc M.
        • Guttridge D.C.
        • Fearon K.C.H.
        Cancer-associated cachexia.
        Nat Rev Dis Primers. 2018; 4: 17105
        • Cederholm T.
        • Jensen G.L.
        • Correia M.
        • et al.
        GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community.
        Clin Nutr. 2019; 38: 1-9
      2. ANZSSFR Task Force on Diagnostic Criteria for Sarcopenia. Statement on announcement of ICD-10-AM code for sarcopenia. https://static1.squarespace.com/static/5a71028fa803bb54cb6b5bad/t/5d1980e513050b000173484e/1561952487142/ANZSSFR+Taskforce+Sarcopenia+Statement+July+2019.pdf. July 2019. Accessed May 7, 2020.

        • Cederholm T.
        • Barazzoni R.
        • Austin P.
        • et al.
        ESPEN guidelines on definitions and terminology of clinical nutrition.
        Clin Nutr. 2017; 36: 49-64
        • Cruz-Jentoft A.J.
        • Baeyens J.P.
        • Bauer J.M.
        • et al.
        Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.
        Age Ageing. 2010; 39: 412-423
        • Daly L.E.
        • Prado C.M.
        • Ryan A.M.
        A window beneath the skin: How computed tomography assessment of body composition can assist in the identification of hidden wasting conditions in oncology that profoundly impact outcomes.
        Proc Nutr Soc. 2018; 77: 135-151
        • Morley J.E.
        • Abbatecola A.M.
        • Argiles J.M.
        • et al.
        Sarcopenia with limited mobility: An international consensus.
        J Am Med Dir Assoc. 2011; 12: 403-409
        • Fielding R.A.
        • Vellas B.
        • Evans W.J.
        • et al.
        Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International Working Group on Sarcopenia.
        J Am Med Dir Assoc. 2011; 12: 249-256
        • Amini B.
        • Boyle S.P.
        • Boutin R.D.
        • Lenchik L.
        Approaches to assessment of muscle mass and myosteatosis on computed tomography: A systematic review.
        J Gerontol A Biol Sci Med Sci. 2019; 74: 1671-1678
        • Pamoukdjian F.
        • Bouillet T.
        • Levy V.
        • Soussan M.
        • Zelek L.
        • Paillaud E.
        Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: A systematic review.
        Clin Nutr. 2018; 37: 1101-1113
        • Stretch C.
        • Aubin J.M.
        • Mickiewicz B.
        • et al.
        Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas.
        PLOS One. 2018; 13e0196235
        • Shen W.
        • Punyanitya M.
        • Wang Z.
        • et al.
        Total body skeletal muscle and adipose tissue volumes: Estimation from a single abdominal cross-sectional image.
        J Appl Physiol. 2004; 97: 2333-2338
        • Prado C.M.
        • Heymsfield S.B.
        Lean tissue imaging: A new era for nutritional assessment and intervention.
        JPEN J Parenter Enteral Nutr. 2014; 38: 940-953
        • MacDonald A.J.
        • Greig C.A.
        • Baracos V.
        The advantages and limitations of cross-sectional body composition analysis.
        Curr Opin Support Palliat Care. 2011; 5: 342-349
        • Mourtzakis M.
        • Prado C.M.
        • Lieffers J.R.
        • Reiman T.
        • McCargar L.J.
        • Baracos V.E.
        A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care.
        Appl Physiol Nutr Metab. 2008; 33: 997-1006
        • Heymsfield S.B.
        • Wang Z.
        • Baumgartner R.N.
        • Ross R.
        Human body composition: Advances in models and methods.
        Annu Rev Nutr. 1997; 17: 527-558
        • Mitsiopoulos N.
        • Baumgartner R.N.
        • Heymsfield S.B.
        • Lyons W.
        • Gallagher D.
        • Ross R.
        Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography.
        J Appl Physiol. 1998; 85: 115-122
        • Baracos V.E.
        • Mazurak V.C.
        • Bhullar A.S.
        Cancer cachexia is defined by an ongoing loss of skeletal muscle mass.
        Ann Palliat Med. 2018; 8: 3-12
        • Hopkins J.J.
        • Skubleny D.
        • Bigam D.L.
        • Baracos V.E.
        • Eurich D.T.
        • Sawyer M.B.
        Barriers to the interpretation of body composition in colorectal cancer: A review of the methodological inconsistency and complexity of the CT-defined body habitus.
        Ann Surg Oncol. 2018; 25: 1381-1394
        • Boshier P.R.
        • Heneghan R.
        • Markar S.R.
        • Baracos V.E.
        • Low D.E.
        Assessment of body composition and sarcopenia in patients with esophageal cancer: A systematic review and meta-analysis.
        Dis Esophagus. 2018; 31: 1-11
        • Ishihara H.
        • Kondo T.
        • Omae K.
        • et al.
        Sarcopenia and the modified Glasgow prognostic score are significant predictors of survival among patients with metastatic renal cell carcinoma who are receiving first-line sunitinib treatment.
        Target Oncol. 2016; 11: 605-617
        • Kamarajah S.K.
        • Bundred J.
        • Tan B.H.L.
        Body composition assessment and sarcopenia in patients with gastric cancer: A systematic review and meta-analysis.
        Gastric Cancer. 2019; 22: 10-22
        • Kim E.Y.
        • Lee H.Y.
        • Kim Y.S.
        • et al.
        Prognostic significance of cachexia score assessed by CT in male patients with small cell lung cancer.
        Eur J Cancer Care (Engl). 2018; 27e12695
        • Martin L.
        • Birdsell L.
        • Macdonald N.
        • et al.
        Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index.
        J Clin Oncol. 2013; 31: 1539-1547
        • Mintziras I.
        • Miligkos M.
        • Wachter S.
        • Manoharan J.
        • Maurer E.
        • Bartsch D.K.
        Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: Systematic review and meta-analysis.
        Int J Surg. 2018; 59: 19-26
        • Rutten I.J.
        • van Dijk D.P.
        • Kruitwagen R.F.
        • Beets-Tan R.G.
        • Olde Damink S.W.
        • van Gorp T.
        Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients.
        J Cachexia Sarcopenia Muscle. 2016; 7: 458-466
        • Kazemi-Bajestani S.M.
        • Mazurak V.C.
        • Baracos V.
        Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes.
        Semin Cell Dev Biol. 2016; 54: 2-10
        • Sun G.
        • Li Y.
        • Peng Y.
        • et al.
        Can sarcopenia be a predictor of prognosis for patients with non-metastatic colorectal cancer? A systematic review and meta-analysis.
        Int J Colorectal Dis. 2018; 33: 1419-1427
        • Gibson D.J.
        • Burden S.T.
        • Strauss B.J.
        • Todd C.
        • Lal S.
        The role of computed tomography in evaluating body composition and the influence of reduced muscle mass on clinical outcome in abdominal malignancy: A systematic review.
        Eur J Clin Nutr. 2015; 69: 1079-1086
        • Simonsen C.
        • de Heer P.
        • Bjerre E.D.
        • et al.
        Sarcopenia and postoperative complication risk in gastrointestinal surgical oncology: A meta-analysis.
        Ann Surg. 2018; 268: 58-69
        • Shachar S.S.
        • Williams G.R.
        • Muss H.B.
        • Nishijima T.F.
        Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review.
        Eur J Cancer. 2016; 57: 58-67
        • Bozzetti F.
        Forcing the vicious circle: Sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy.
        Ann Oncol. 2017; 28: 2107-2118
        • Sealy M.J.
        • Dechaphunkul T.
        • van der Schans C.P.
        • et al.
        Low muscle mass is associated with early termination of chemotherapy related to toxicity in patients with head and neck cancer.
        Clin Nutr. 2020; 39: 501-509
        • Achim V.
        • Bash J.
        • Mowery A.
        • et al.
        Prognostic indication of sarcopenia for wound complication after total laryngectomy.
        JAMA Otolaryngol Head Neck Surg. 2017; 143: 1159-1165
        • Bril S.I.
        • Pezier T.F.
        • Tijink B.M.
        • Janssen L.M.
        • Braunius W.W.
        • de Bree R.
        Preoperative low skeletal muscle mass as a risk factor for pharyngocutaneous fistula and decreased overall survival in patients undergoing total laryngectomy.
        Head Neck. 2019; 41: 1745-1755
        • Liberati A.
        • Altman D.G.
        • Tetzlaff J.
        • et al.
        The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration.
        PLoS Med. 2009; 6e1000100
        • Halyard M.Y.
        • Jatoi A.
        • Sloan J.A.
        • et al.
        Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4).
        Int J Radiat Oncol Biol Phys. 2007; 67: 1318-1322
        • Lund L.
        • Ross L.
        • Petersen M.A.
        • Groenvold M.
        Cancer caregiving tasks and consequences and their associations with caregiver status and the caregiver’s relationship to the patient: A survey.
        BMC Cancer. 2014; 14: 541
        • Academy of Nutrition and Dietetics
        Evidence Analysis Manual: Steps in the Academy Evidence Analysis Process.
        Academy of Nutrition and Dietetics, Chicago, IL2016
        • Stene G.B.
        • Helbostad J.L.
        • Amundsen T.
        • et al.
        Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer.
        Acta Oncol. 2015; 54: 340-348
      3. GRADEpro GDT: GRADEpro Guideline Development Tool [software]. McMaster University (developed by Evidence Prime, Inc), 2015 (Available from http://gradepro.org)
        • Guyatt G.
        • Oxman A.D.
        • Akl E.A.
        • et al.
        GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.
        J Clin Epidemiol. 2011; 64: 383-394
        • Kallogjeri D.
        • Francis D.O.
        • Piccirillo J.F.
        Use of confidence intervals to improve the quality of research results reporting and interpretation.
        JAMA Otolaryngol Head Neck Surg. 2019; 145: 491-493
        • Chargi N.
        • Bril S.I.
        • Emmelot-Vonk M.H.
        • de Bree R.
        Sarcopenia is a prognostic factor for overall survival in elderly patients with head-and-neck cancer.
        Eur Arch Otorhinolaryngol. 2019; 276: 1475-1486
        • Cho Y.
        • Kim J.W.
        • Keum K.C.
        • Lee C.G.
        • Jeung H.C.
        • Lee I.J.
        Prognostic significance of sarcopenia with inflammation in patients with head and neck cancer who underwent definitive chemoradiotherapy.
        Front Oncol. 2018; 8: 457
        • Fattouh M.
        • Chang G.Y.
        • Ow T.J.
        • et al.
        Association between pretreatment obesity, sarcopenia, and survival in patients with head and neck cancer.
        Head Neck. 2019; 41: 707-714
        • Grossberg A.J.
        • Chamchod S.
        • Fuller C.D.
        • et al.
        Association of body composition with survival and locoregional control of radiotherapy-treated head and neck squamous cell carcinoma.
        JAMA Oncol. 2016; 2: 782-789
        • Kabarriti R.
        • Bontempo A.
        • Romano M.
        • et al.
        The impact of dietary regimen compliance on outcomes for HNSCC patients treated with radiation therapy.
        Support Care Cancer. 2018; 26: 3307-3313
        • Pai P.C.
        • Chuang C.C.
        • Chuang W.C.
        • et al.
        Pretreatment subcutaneous adipose tissue predicts the outcomes of patients with head and neck cancer receiving definitive radiation and chemoradiation in Taiwan.
        Cancer Med. 2018; 7: 1630-1641
        • Tamaki A.
        • Manzoor N.F.
        • Babajanian E.
        • Ascha M.
        • Rezaee R.
        • Zender C.A.
        Clinical significance of sarcopenia among patients with advanced oropharyngeal cancer.
        Otolaryngol Head Neck Surg. 2019; 160: 480-487
        • Wendrich A.W.
        • Swartz J.E.
        • Bril S.I.
        • et al.
        Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer.
        Oral Oncol. 2017; 71: 26-33
        • Jung A.R.
        • Roh J.L.
        • Kim J.S.
        • et al.
        Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer.
        Eur J Cancer. 2019; 116: 98-106
        • Ganju R.G.
        • Morse R.
        • Hoover A.
        • TenNapel M.
        • Lominska C.E.
        The impact of sarcopenia on tolerance of radiation and outcome in patients with head and neck cancer receiving chemoradiation.
        Radiother Oncol. 2019; 137: 117-124
        • Nishikawa D.
        • Hanai N.
        • Suzuki H.
        • Koide Y.
        • Beppu S.
        • Hasegawa Y.
        The impact of skeletal muscle depletion on head and neck squamous cell carcinoma.
        ORL J Otorhinolaryngol Relat Spec. 2018; 80: 1-9
        • Prado C.M.M.
        • Baracos V.E.
        • McCargar L.J.
        • Reiman T.
        • Mourtzakis M.
        • Tonkin K.
        Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment.
        Clin Cancer Res. 2009; 15: 2920-2926
        • Mokdad A.H.
        • Ford E.S.
        • Bowman B.A.
        • et al.
        Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.
        JAMA. 2003; 289: 76-79
        • Prado C.M.
        • Lieffers J.R.
        • McCargar L.J.
        • et al.
        Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study.
        Lancet Oncol. 2008; 9: 629-635
        • Parsons H.A.
        • Baracos V.E.
        • Dhillon N.
        • Hong D.S.
        • Kurzrock R.
        Body composition, symptoms, and survival in advanced cancer patients referred to a phase I service.
        PLOS One. 2012; 7e29330
        • Go S.I.
        • Park M.J.
        • Song H.N.
        • et al.
        Sarcopenia and inflammation are independent predictors of survival in male patients newly diagnosed with small cell lung cancer.
        Support Care Cancer. 2016; 24: 2075-2084
        • Kim Y.S.
        • Lee Y.
        • Chung Y.S.
        • et al.
        Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys.
        J Gerontol A Biol Sci Med Sci. 2012; 67: 1107-1113
        • Baracos V.E.
        • Arribas L.
        Sarcopenic obesity: Hidden muscle wasting and its impact for survival and complications of cancer therapy.
        Ann Oncol. 2018; 29: ii1-ii9
        • Derstine B.A.
        • Holcombe S.A.
        • Ross B.E.
        • Wang N.C.
        • Su G.L.
        • Wang S.C.
        Skeletal muscle cutoff values for sarcopenia diagnosis using T10 to L5 measurements in a healthy US population.
        Sci Rep. 2018; 8: 11369
        • Swartz J.E.
        • Pothen A.J.
        • Wegner I.
        • et al.
        Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients.
        Oral Oncol. 2016; 62: 28-33
        • Bril S.I.
        • Wendrich A.W.
        • Swartz J.E.
        • et al.
        Interobserver agreement of skeletal muscle mass measurement on head and neck CT imaging at the level of the third cervical vertebra.
        Eur Arch Otorhinolaryngol. 2019; 276: 1175-1182
        • Recio-Boiles A.
        • Galeas J.N.
        • Goldwasser B.
        • et al.
        Enhancing evaluation of sarcopenia in patients with non-small cell lung cancer (NSCLC) by assessing skeletal muscle index (SMI) at the first lumbar (L1) level on routine chest computed tomography (CT).
        Support Care Cancer. 2018; 26: 2353-2359
        • Martin L.
        • Hopkins J.
        • Malietzis G.
        • et al.
        Assessment of computed tomography (CT)-defined muscle and adipose tissue features in relation to short-term outcomes after elective surgery for colorectal cancer: A multicenter approach.
        Ann Surg Oncol. 2018; 25: 2669-2680
        • Ebadi M.
        • Martin L.
        • Ghosh S.
        • et al.
        Subcutaneous adiposity is an independent predictor of mortality in cancer patients.
        Br J Cancer. 2017; 117: 148-155
        • Janssen I.
        • Heymsfield S.B.
        • Wang Z.M.
        • Ross R.
        Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr.
        J Appl Physiol. 2000; 89: 81-88
        • Valera B.
        • Sohani Z.
        • Rana A.
        • Poirier P.
        • Anand S.S.
        The ethnoepidemiology of obesity.
        Can J Cardiol. 2015; 31: 131-141
        • Lear S.A.
        • Kohli S.
        • Bondy G.P.
        • Tchernof A.
        • Sniderman A.D.
        Ethnic variation in fat and lean body mass and the association with insulin resistance.
        J Clin Endocrinol Metab. 2009; 94: 4696-4702
        • Hilmi M.
        • Jouinot A.
        • Burns R.
        • et al.
        Body composition and sarcopenia: The next-generation of personalized oncology and pharmacology?.
        Pharmacol Ther. 2019; 196: 135-159
        • Chaturvedi A.K.
        Epidemiology and clinical aspects of HPV in head and neck cancers.
        Head Neck Pathol. 2012; 6 Suppl 1: S16-S24
        • Langius J.A.
        • Bakker S.
        • Rietveld D.H.
        • et al.
        Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy.
        Br J Cancer. 2013; 109: 1093-1099
        • Citak E.
        • Tulek Z.
        • Uzel O.
        Nutritional status in patients with head and neck cancer undergoing radiotherapy: A longitudinal study.
        Support Care Cancer. 2019; 27: 239-247
        • Prado C.M.
        • Cushen S.J.
        • Orsso C.E.
        • Ryan A.M.
        Sarcopenia and cachexia in the era of obesity: Clinical and nutritional impact.
        Proc Nutr Soc. 2016; 75: 188-198
        • Beaudart C.
        • Zaaria M.
        • Pasleau F.
        • Reginster J.Y.
        • Bruyere O.
        Health outcomes of sarcopenia: A systematic review and meta-analysis.
        PLoS One. 2017; 12: e0169548
        • Bruyere O.
        • Beaudart C.
        • Ethgen O.
        • Reginster J.Y.
        • Locquet M.
        The health economics burden of sarcopenia: A systematic review.
        Maturitas. 2019; 119: 61-69
        • Zamboni M.
        • Gattazzo S.
        • Rossi A.P.
        Myosteatosis: A relevant, yet poorly explored element of sarcopenia.
        Eur Geriatr Med. 2019; 10: 5-6

      Biography

      M. Findlay is executive research lead–cancer nutrition, oncology specialist dietitian, Royal Prince Alfred Hospital, Camperdown, Australia; oncology dietetics clinical research fellow, Chris O’Brien Lifehouse, New South Wales, Australia; and an adjunct senior lecturer and PhD candidate, Cancer Nursing Research Unit, Susan Wakil School of Nursing and Midwifery, Faculty of Medicine and Health, University of Sydney, New South Wales, Australia.

      Biography

      K. White is a professor of cancer nursing, Cancer Nursing Research Unit, Susan Wakil School of Nursing and Midwifery, Faculty of Medicine and Health, University of Sydney, New South Wales, Australia.

      Biography

      M. Lai is research officer, Cancer Nursing Research Unit, Susan Wakil School of Nursing and Midwifery, Faculty of Medicine and Health, University of Sydney, New South Wales, Australia.

      Biography

      D. Luo is research officer, Cancer Nursing Research Unit, Susan Wakil School of Nursing and Midwifery, Faculty of Medicine and Health, University of Sydney, New South Wales, Australia.

      Biography

      J. D. Bauer is an associate professor of nutrition and dietetics, School of Human Movement and Nutrition Sciences, University of Queensland, Brisbane, Australia.